According to a recent FMI study, the global Infection Prevention Market Share is expected to reach US$ 37.4 billion in 2021. In response to rising demand for sterilisation equipment and protective clothing in hospitals and clinical laboratories, the market is expected to exceed $56.4 billion by 2031, growing 1.5X.
Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13950
Between 2016 and 2020, the market grew at a CAGR of 3.2%. The market is being driven by rising concerns about sterilisation and disinfection, as well as a greater emphasis on high-level infection prevention. Driven by this, the infection prevention market is anticipated to expand at 4.2% CAGR during the forecast period 2021-2031.
Since the last decade, there have been numerous outbreaks of various infectious diseases caused by pathogens such as viruses, bacteria, fungi, and other parasites. According to the Centers for Disease Control and Prevention (CDC), infectious diseases were the third leading cause of death in the United States in 2018, trailing parasitic diseases (15.5 million cases) and tuberculosis (9,025 cases).
As a result, the market is seeing an increase in the demand for effective solutions to prevent infections and provide measures to reduce the risk of transmission.
The growing number of surgical procedures performed around the world is driving up demand for sterilisation equipment used to disinfect surgical tools. As a result, FMI predicts that disinfectors will become the most widely used infection prevention product, accounting for nearly 30% of total sales through 2031.
“Implementation of stringent regulations, mandating the use of infection prevention products such as sanitizers, surgical masks, and others across various industries is intended at countering the spread of COVID-19. This will continue accelerating the sales of infection prevention solutions over the assessment period,” says a FMI analyst.
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-13950
Key Takeaways from the Infection Prevention Market Analysis
- The United States is expected to dominate the market in North America, accounting for more than 95% of infection prevention product sales by the end of 2021.
- Because of the implementation of infection prevention and control programmes at health care facilities, the United Kingdom and Germany are expected to account for more than 40% of sales in the Europe market in 2021.
- China is expected to be the most profitable market in East Asia, accounting for nearly 27% of regional revenue in 2021.
- The market in India is expected to contribute more than 50% of sales in the South Asia market by 2021, thanks to improvements in medical care facilities and healthcare services.
- Based on end use, the hospitals and clinics segment is anticipated to project the fastest growth, expanding at a CAGR of 3.4% through 2031.
Key Drivers
- Surging demand for industrial disinfectants and cleaners owing to increasing awareness amongst healthcare service providers across North America and Europe is spurring the sales of infection prevention products.
- Increasing demand for personal protective products such as surgical gloves and marks due to the outbreak of the novel coronavirus is pushing the protective apparel and textiles segment growth.
Key Restraints
- Implementation of stringent regulations by regulatory bodies such as the Food and Drug Administration (FDA) on the proper disposal of waste generated by disinfectants production is hampering the market growth.
- Long term usage of infection prevention products such as chemical agents and disinfectants may lead to chronic health issues such as respiratory irritation, cancer, mutagenic changes, headaches, and breath-shortening, which is, in turn, hindering the market.
Competitive Landscape
Key players in the global infection prevention market are adopting expansion strategies such novel product development, speedy regulatory approvals, clinical trials, acquisition, and partnerships to expand their market share and strengthen their global footprint. For instance,
- In December 2020, Getinge AB, a global medical technology company based in Sweden, announced launching a Stainless Steel DPTE® Beta Containers. The containers are designed to prevent the spread of infections by efficient loading and unloading into sterile zones.
- In February 2019, Cantel Medical Corp., innovative infection prevention manufacturers in the U.S. announced acquiring an Italian based company, Omnia S.p.A. to expand its product portfolio with surgical consumable solutions.
Request for Customization @ https://www.futuremarketinsights.com/customization-available/REP-GB-13950
Leading players operating in the market profiled by FMI are:
- Cantel Medical
- Getinge AB
- STERIS
- ASP (Advanced sterilization Products)
- Sotera Health
- 3M
- Ecolab
- Halyard Worldwide, Inc. (Halyard health)
- Matachana Group
- Belimed, Inc.
- Pal International
- Reckitt Benckiser Group PLC.
- Metrex Research, LLC.
- Terumo Corporation
